This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_BREAST_LOBULAR_EXALLC for full statistics.
Carcinoma in situ of breast, lobular
CD2_INSITU_BREAST_LOBULAR
breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
244 |
4. Check minimum number of eventsNone |
244 |
5. Include endpointsNone |
244 |
6. Filter based on genotype QC (FinnGen only) |
244 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D05
- Name in latin
- Carcinoma in situ lobulare mammae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of breast, lobular
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of breast, lobular
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 244 | 244 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 58.32 | 58.32 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 214
- Matched controls
- 2140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05.0
ICD-10 Finland
Lobular carcinoma in situ
+∞
306.6
213
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
62.3
102.4
119
42
PJA12
NOMESCO Finland
Sentinel node biopsy
13.4
55.3
112
162
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
33.3
43.5
57
23
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
12.0
41.7
84
109
HA1AA
NOMESCO Finland
X-ray mammography
10.2
40.8
92
147
HAC20
NOMESCO Finland
Total mastectomy
14.4
39.6
71
71
115
Kela drug reimbursment
Breast cancer
8.5
35.9
91
171
HAB40
NOMESCO Finland
Wedge excision of mammary gland
10.7
35.9
76
105
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
377.5
32.8
32
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
15.3
31.7
54
46
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
34.8
31.2
40
14
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
25.6
28.7
40
19
TQW20
NOMESCO Finland
Tatoe
40.1
27.5
34
10
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
7.6
25.1
64
113
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
64.0
24.7
28
5
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
41.6
23.7
29
8
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.4
22.2
48
64
N63
ICD-10 Finland
Unspecified lump in breast
7.4
21.8
56
98
C50.99
ICD-10 Finland
Breast, unspecified
9.7
21.4
45
57
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
16.9
20.2
32
22
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
14.2
19.9
34
28
L02BA01
ATC
tamoxifen; oral
7.3
17.9
45
75
HAE99
NOMESCO Finland
Other reconstruction of breast
46.3
17.6
21
5
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
9.0
17.6
38
50
L02BG04
ATC
letrozole; oral
6.0
17.3
51
106
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
10.6
16.9
33
36
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
7.4
16.7
41
66
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
5.9
16.5
49
102
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
6.2
16.1
46
91
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
12.2
16.1
29
27
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
11.4
16.1
30
30
ZZR10
NOMESCO Finland
Flap of skin and muscle
27.4
15.0
20
8
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
7.7
14.5
34
51
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
10.0
13.2
26
29
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
7.0
12.9
32
52
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
28.6
12.2
16
6
ZZF00
NOMESCO Finland
Graft of adipose tissue
22.9
12.2
17
8
C50
ICD-10 Finland
Malignant neoplasm of breast
8.0
12.0
27
38
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
10.2
11.8
23
25
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.8
11.5
33
65
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
11.1
100
514
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
10.5
11.0
21
22
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
10.9
109
592
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
7.2
10.9
26
40
XX3DW
NOMESCO Finland
Time consuming IT work
3.9
10.9
48
148
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
10.0
10.8
21
23
D24
ICD-10 Finland
Benign neoplasm of breast
10.0
10.8
21
23
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
10.5
86
411
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
34.4
10.5
13
*
A04AA02
ATC
granisetron; systemic, transdermal
4.8
10.3
35
84
H02AB02
ATC
dexamethasone; systemic
3.6
10.1
49
164
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
27.5
9.9
13
5
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
13.2
9.5
16
13
TQB05
NOMESCO Finland
Puncture of skin of trunk
16.5
9.2
14
9
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
17.2
8.7
13
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
8.6
74
355
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
6.0
8.6
23
42
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.5
8.4
21
35
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
8.7
8.3
17
21
X76
ICPC
Malignant neoplasm breast female
6.3
8.2
21
36
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
26.1
7.6
10
*
Z31.5
ICD-10 Finland
Genetic counselling
4.5
7.5
26
64
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
14.0
7.5
12
9
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
5.9
7.4
20
37
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.1
7.4
28
75
ZXA05
NOMESCO Finland
Left side
2.4
7.2
71
365
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.3
7.2
21
43
L02BG03
ATC
anastrozole; oral
6.8
6.8
16
25
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
8.2
6.7
14
18
HAD99
NOMESCO Finland
Other plastic operation on breast
12.8
6.7
11
9
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
6.6
110
714
NK6AN
NOMESCO Finland
Total body bone isotope imaging
8.6
6.4
13
16
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
8.6
6.4
13
16
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
18.7
6.3
9
5
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
38
79
5.51
17.99
2.7
3.4
u/ml
45.1
26.6
0.40
38
79
(40768793) Breast Pathology biopsy report
42
106
4.58
15.80
1.5
1.3
—
—
—
0
0
(4035726)
58
234
2.94
10.61
1.7
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
62
291
2.52
8.29
1.4
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
101
651
1.94
5.81
2.3
2.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
24
5.21
5.80
1.3
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
161
1217
1.95
5.65
8.0
5.7
umol/l
8.9
9.8
1.62
153
1136
(1617658) Protocol used for examination of sentinel lymph nodes
17
47
3.81
5.59
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
131
965
1.77
4.60
2.9
2.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
49
268
2.04
4.37
4.4
3.9
ug/l
5.0
11.9
1.55
38
226
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
201
1729
1.92
3.74
9.6
7.2
u/l
82.4
79.3
0.27
194
1600
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
129
992
1.64
3.53
4.0
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
156
1263
1.65
3.44
9.6
8.7
e9/l
3.6
3.9
1.26
136
1100
(3015377) Calcium [Moles/volume] in Serum or Plasma
110
820
1.62
3.37
4.1
3.4
mmol/l
2.4
2.4
2.08
99
711
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
61
2.74
3.20
2.3
1.5
iu/l
4.3
6.2
—
6
18
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
140
1138
1.54
2.76
7.6
5.6
mmol/l
1.2
1.2
0.67
120
949
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
70
497
1.57
2.50
2.3
2.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
237
2256
2.76
2.25
19.5
16.0
umol/l
70.2
69.7
0.17
237
2256
(3013707) Erythrocyte sedimentation rate by Westergren method
188
1669
1.55
2.18
3.9
4.3
mm/h
13.0
12.9
0.03
170
1517
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
55
0.00
2.09
0.0
2.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
511
0.61
1.92
1.4
1.2
u/ml
0.5
2.6
—
6
141
(40758558) Short blood count panel - Blood
73
559
1.44
1.76
7.2
6.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
19
3.21
1.67
8.3
2.8
nmol/l
9.4
3.4
—
6
19
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
107
1.84
1.60
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
176
1585
1.40
1.53
3.6
3.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
15
3.38
1.53
1.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
102
851
1.34
1.43
5.9
7.8
inr
1.1
1.1
0.47
28
256
(3051611) Lipemic interference index of Serum or Plasma
5
17
2.98
1.36
6.2
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
64
500
1.38
1.36
3.3
3.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
106
1.75
1.33
1.2
1.3
—
—
—
0
0
(4306422)
6
24
2.54
1.31
1.0
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
189
1740
1.38
1.30
19.7
17.8
g/l
329.5
330.1
0.41
189
1732
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
224
2129
1.64
1.30
14.9
13.1
mg/l
24.4
20.7
0.69
181
1635
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
53
407
1.39
1.24
3.6
3.8
ng/l
89.2
159.1
0.51
37
313
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
120
1041
1.30
1.23
5.7
4.8
mmol/l
1.2
1.2
0.57
113
937
(3024561) Albumin [Mass/volume] in Serum or Plasma
111
954
1.30
1.22
4.3
3.7
g/l
36.5
35.8
0.78
100
889
(3021589) Normoblasts [#/volume] in Blood
111
955
1.30
1.21
9.5
9.0
e9/l
0.0
0.0
0.86
90
778
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
116
1005
1.29
1.19
2.5
2.3
nmol/l
85.0
80.4
0.88
107
880
(3009542) Hematocrit [Volume Fraction] of Blood
201
1878
1.40
1.19
17.0
14.3
%
37.7
39.2
1.20
144
1274
(3026493) Urate [Moles/volume] in Serum or Plasma
40
528
0.71
1.17
2.7
2.5
umol/l
332.0
7180.0
2.75
35
444
(3019230) Fractional oxyhemoglobin in Venous blood
0
36
0.00
1.15
0.0
1.8
—
54.0
—
0
36
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
11
59
1.91
1.09
1.1
2.3
%
95.7
95.0
0.02
11
53
(3025130) Human papilloma virus identified in Specimen
7
32
2.22
1.09
2.1
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
82
686
1.29
1.08
3.8
3.0
u/l
34.1
28.9
0.39
75
650
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
43
327
1.38
1.07
3.3
2.9
e6/l
2.9
3.8
0.36
21
158
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
46
1.99
1.05
1.0
1.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
12
200
0.58
1.04
2.4
1.9
nmol/l
316.0
368.9
0.38
12
190
(42870588) Differential panel, method unspecified - Blood
81
683
1.28
1.00
4.3
5.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
33
243
1.41
0.99
16.7
17.2
inr
1.3
1.2
—
8
38
(3042631) Mycobacterium sp identified in Specimen
0
29
0.00
0.98
0.0
3.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
32
0.00
0.96
0.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
215
2051
1.41
0.94
16.8
12.8
ml/min/173m2
77.1
78.1
0.37
183
1666
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
143
1.51
0.93
1.5
1.5
—
—
—
0
0
(3000492) Spirometry study
25
177
1.46
0.93
1.8
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
492
1.29
0.91
1.4
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
36
277
1.35
0.85
1.8
2.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
63
525
1.27
0.85
4.1
3.3
%
102.5
95.9
1.47
63
510
(3002030) Lymphocytes/100 leukocytes in Blood
113
1007
1.23
0.84
5.0
5.7
%
28.9
28.8
0.03
108
925
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
132
1.48
0.78
1.2
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
27
0.00
0.78
0.0
8.3
—
6.7
—
0
20
(3019309) Folate [Moles/volume] in Red Blood Cells
31
398
0.75
0.77
2.0
1.7
nmol/l
1066.4
1251.1
0.64
24
280
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
26.6
—
0
23
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
54
449
1.26
0.74
2.8
2.5
mmol/l
2.5
2.5
0.77
48
398
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
106
0.56
0.74
1.8
3.2
kpa
4.7
5.2
—
6
98
(3049717) Cytology report of Urine Cyto stain
10
60
1.70
0.73
1.5
2.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
28
213
1.36
0.72
3.5
3.4
mmol/l
1.2
1.2
0.03
28
183
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
26
1.94
0.71
1.0
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
72
623
1.22
0.69
2.6
2.9
ng/l
683.0
954.9
0.68
62
521
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
61
1.67
0.69
1.8
1.9
ug/l
932.6
220.1
—
10
54
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
42
1.69
0.69
3.1
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
50
593
0.80
0.68
2.8
4.4
estimate
0.0
0.0
0.00
15
205
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
43
1.65
0.67
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
1.6
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
522
1.22
0.65
1.5
1.7
mg/l
2.0
1.0
0.45
54
420
(3026008) Bacteria identified in Urine by Culture
68
777
0.83
0.64
3.6
3.0
—
—
—
0
0
(3009343) pH of Capillary blood
6
105
0.56
0.63
1.5
3.2
—
7.4
—
0
18
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
44
365
1.25
0.62
2.8
2.6
e6/l
1.2
1.1
0.08
22
195
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
20
0.00
0.60
0.0
4.1
—
—
—
0
0
(3013512) EKG study
77
680
1.19
0.60
4.0
3.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
82
916
0.84
0.60
2.0
1.9
pmol/l
100.4
99.3
0.07
36
399
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
115
0.60
0.59
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
88
0.56
0.57
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
80
716
1.17
0.53
3.4
3.1
—
—
—
0
0
(4010399)
12
167
0.70
0.51
1.2
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
51
442
1.19
0.49
2.3
2.5
e6/l
5.1
6.0
0.39
39
393
(3019198) Lymphocytes [#/volume] in Blood
116
1075
1.15
0.48
4.8
5.3
e9/l
1.9
1.9
0.11
99
947
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
68
1.49
0.47
1.1
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
49
1.44
0.46
6.3
4.2
—
—
—
0
0
(3019225) pH of Specimen
27
220
1.26
0.46
7.0
3.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
77
695
1.16
0.46
2.7
2.1
u/l
54.7
54.8
0.01
68
626
(3013826) Glucose [Moles/volume] in Serum or Plasma
131
1228
1.14
0.46
3.5
4.0
mmol/l
6.5
6.5
0.06
124
1141
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
221
2156
1.27
0.45
4.7
4.7
mmol/l
4.9
4.9
0.30
205
1976
(3006315) Basophils [#/volume] in Blood
114
1060
1.14
0.44
4.9
5.3
e9/l
0.0
0.0
1.03
94
908
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
104
1.37
0.44
1.2
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
21
261
0.79
0.44
2.2
2.2
%
22.7
21.2
0.18
16
216
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
11
78
1.43
0.44
4.9
2.7
g/l
1.5
0.7
0.29
11
71
(40761535) Cells panel - Urine sediment
14
184
0.75
0.43
2.4
3.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
206
0.76
0.43
4.1
2.6
ml/min/173m2
67.3
65.8
—
6
76
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
87
1.40
0.43
5.8
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
82
748
1.14
0.42
4.7
3.7
e6/l
111.8
87.6
0.16
53
517
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
40.9
—
0
10
(44813793)
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
649.1
—
0
10
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
279.9
—
0
10
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
16
0.00
0.41
0.0
1.6
—
10.1
—
0
16
(36660697) Celiac disease serology panel - Serum
12
160
0.74
0.41
1.4
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
113
1055
1.13
0.41
4.8
5.3
e9/l
0.6
0.5
0.37
94
904
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
0.1
—
0
6
(40761511) CBC panel - Blood by Automated count
225
2204
1.27
0.40
14.7
12.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.5
—
1.0
—
0
8
(3028707) Methadone [Presence] in Urine by Screen method
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
28
235
1.22
0.38
2.5
3.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
69
628
1.14
0.36
3.6
3.1
e6/l
20.4
32.6
0.53
49
472
(3030467) Casts [#/volume] in Urine by Automated count
65
590
1.14
0.36
3.3
3.0
e6/l
0.3
0.5
0.43
44
429
(21494755) Public health laboratory ask at order entry panel
9
125
0.71
0.36
1.2
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
25
209
1.22
0.35
2.4
2.1
u/l
27.6
28.7
0.13
19
175
(3007164) IgA [Mass/volume] in Serum or Plasma
38
433
0.86
0.35
1.2
1.5
g/l
2.1
2.4
0.52
17
244
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
44
495
0.86
0.35
2.3
2.1
mg/l
2.5
3.3
2.16
36
418
(3008037) Lactate [Moles/volume] in Venous blood
6
44
1.37
0.34
4.0
2.5
mmol/l
1.4
1.4
—
6
44
(40761536) Microorganisms panel - Urine sediment
15
188
0.78
0.34
3.2
4.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
133
0.74
0.34
3.0
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
342
1.17
0.34
1.6
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
44
390
1.16
0.34
3.2
2.7
mosm/kgh2o
485.8
509.4
0.35
29
336
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
6
86
0.69
0.33
1.2
1.2
—
2.8
—
0
6
(3009508) Creatinine [Moles/volume] in Urine
71
652
1.13
0.33
2.8
2.9
mmol/l
6.2
6.6
0.48
59
529
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
173
1788
0.89
0.33
5.4
4.5
pmol/l
15.1
14.9
0.42
159
1610
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
167
1.22
0.29
1.6
1.1
iu/ml
183.1
139.8
—
9
69
(36304419) Bacteria [Presence] in Urine
63
579
1.12
0.29
3.2
2.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
10
76
1.33
0.28
5.3
2.2
g/l
39.3
38.1
—
10
71
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
85
1.31
0.28
5.5
2.1
g/l
11.8
10.3
0.21
11
77
(3052851) Hemolysis interference index of Serum or Plasma
8
62
1.30
0.28
7.5
2.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
79
737
1.11
0.28
5.0
3.5
ph
7.4
7.4
0.49
17
145
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
235
0.84
0.27
2.0
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
72
670
1.11
0.26
1.6
1.6
mmol/l
1.3
1.4
0.11
52
554
(3003694) ABO and Rh group [Type] in Blood
56
514
1.12
0.26
1.1
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
5
72
0.69
0.26
1.2
2.1
g/l
2.0
1.6
—
5
62
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
210
2059
1.14
0.26
4.1
4.1
mmol/l
1.3
1.3
0.05
191
1861
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
170
0.81
0.26
2.9
4.7
mmol/l
1.5
1.2
0.20
14
163
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
218
2143
1.16
0.26
4.6
4.6
mmol/l
1.6
1.6
0.33
199
1953
(3013115) Eosinophils [#/volume] in Blood
115
1097
1.09
0.25
4.9
5.5
e9/l
0.2
0.2
0.08
98
958
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
233
0.85
0.25
2.0
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
53
487
1.11
0.25
2.8
4.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
39
431
0.89
0.25
1.3
1.3
u/ml
8.9
13.1
0.29
17
165
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
82
0.73
0.24
1.2
1.2
—
3.8
—
0
16
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
83
0.72
0.24
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
84
0.71
0.24
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
85
0.70
0.24
1.3
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
139
1340
1.09
0.23
4.1
2.8
u/l
57.8
43.5
0.59
122
1227
(3027273) Bicarbonate [Moles/volume] in Venous blood
7
93
0.75
0.23
4.1
2.6
mmol/l
25.6
25.5
—
7
93
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
98
1.24
0.21
1.4
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
104
0.76
0.21
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
11.9
—
0
11
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
143.0
—
0
11
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
9.5
—
0
10
(3028433) Virus identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4027681)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
12
0.00
0.21
0.0
1.4
—
0.9
—
0
7
(3038515) Glucose [Moles/volume] in Venous blood
5
43
1.17
0.21
4.6
2.5
mmol/l
6.2
7.0
—
5
43
(40768797) Stomach Pathology biopsy report
32
354
0.89
0.21
1.4
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
123
0.81
0.21
1.5
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
13
0.00
0.21
0.0
1.2
—
1.3
—
0
7
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
79
748
1.08
0.20
3.4
3.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
2.0
—
0
14
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
113
1087
1.07
0.19
3.0
3.9
estimate
0.0
0.0
0.00
14
199
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
289
0.89
0.18
6.2
6.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
223
2203
1.14
0.18
5.2
5.3
mmol/l
2.8
2.9
0.24
206
2004
(3021960) Folate [Moles/volume] in Serum or Plasma
50
535
0.92
0.18
1.6
1.5
nmol/l
23.7
23.2
0.09
42
442
(4094501)
7
60
1.17
0.18
1.0
1.0
—
—
—
0
0
(4034850)
7
61
1.15
0.17
5.9
9.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
67
0.74
0.17
1.2
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
67
0.74
0.17
4.4
5.6
mmol/l
1.0
1.2
—
5
60
(3012516) Albumin [Mass/volume] in Urine
67
635
1.08
0.17
2.9
3.0
mg/l
14.5
143.9
0.59
45
358
(3035350) Ketones [Presence] in Urine by Test strip
110
1062
1.07
0.16
3.0
3.9
estimate
0.0
0.0
0.00
14
203
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
25
226
1.12
0.16
4.6
2.2
umol/l
6.9
6.3
0.12
20
195
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
80
0.74
0.15
1.2
1.2
—
2.2
—
0
12
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
78
815
0.94
0.15
3.2
3.5
ng/l
26.7
62.7
0.40
51
575
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
43
459
0.92
0.15
1.8
1.7
pmol/l
162857580.9
480.8
0.49
35
348
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
7
88
0.79
0.15
1.7
3.2
mmol/l
24.6
25.0
—
7
79
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
7
88
0.79
0.15
5.4
2.9
%
44.6
43.6
—
7
88
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
79
823
0.94
0.14
2.9
4.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
97
0.82
0.14
3.0
2.7
u/ml
16.3
1484.4
—
8
85
(3012544) pH of Venous blood
16
180
0.88
0.13
3.0
3.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
111
1077
1.06
0.13
4.6
5.1
estimate
0.0
0.0
0.00
14
200
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
218
2157
1.10
0.13
4.8
4.8
mmol/l
5.9
5.9
0.05
198
1953
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
209
2065
1.08
0.13
6.0
5.3
mu/l
1.8
2.5
0.59
194
1864
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
11
94
1.18
0.13
3.5
6.2
mmol/l
24.3
24.9
0.36
11
89
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
123
1.15
0.13
2.5
1.6
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
13
114
1.15
0.12
3.2
6.7
%
0.9
0.7
1.28
13
114
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
13
114
1.15
0.12
3.2
6.7
%
1.2
1.4
0.32
13
114
(3005322) IgE [Units/volume] in Serum or Plasma
15
134
1.13
0.11
1.1
1.2
u/ml
60.5
161.9
2.23
15
124
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
46
1.09
0.09
1.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
47
1.07
0.09
8.6
5.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
47
1.07
0.09
1.0
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
54
1.11
0.09
1.2
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
59
569
1.05
0.08
2.8
3.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
60
0.83
0.08
9.6
4.9
—
3.4
—
0
7
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
195
0.92
0.08
1.6
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
63
0.79
0.08
1.2
1.1
—
38.6
—
0
7
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
156
1.10
0.08
1.9
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
164
0.91
0.08
1.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
53
511
1.05
0.08
3.0
3.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
74
1.08
0.07
1.4
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
20
186
1.08
0.07
3.3
6.1
g/l
115.0
118.8
0.42
20
181
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
77
1.04
0.07
1.5
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
31
326
0.94
0.07
1.9
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
206
1.07
0.07
1.7
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
30
285
1.06
0.07
1.7
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
295
0.94
0.07
5.1
4.4
%
32.7
33.5
0.20
19
180
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
89
1.13
0.07
1.9
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
89
1.13
0.07
1.5
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
132
0.90
0.07
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
99
1.12
0.06
1.5
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
102
0.88
0.06
4.6
6.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
105
0.85
0.06
1.6
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
218
1.06
0.05
1.7
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
23
218
1.06
0.05
3.3
6.0
kpa
5.2
5.2
0.14
23
213
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
443
0.96
0.04
1.2
1.3
iu/ml
30.2
35.1
0.14
15
152
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
206
2048
1.04
0.04
5.9
5.7
mmol/mol
39.7
39.4
0.22
190
1881
(3037467) Urinalysis macro (dipstick) panel - Urine
150
1486
1.02
0.04
4.4
4.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
68
667
1.03
0.04
3.8
3.8
mg/mmol
5.3
6.3
0.11
46
366
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
17
161
1.06
0.03
2.1
2.7
—
5.5
—
0
5
(3019150) Specific gravity of Urine by Refractometry
46
471
0.97
0.03
2.5
4.3
kg/l
1.0
1.0
—
9
60
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
92
1.09
0.03
1.3
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
120
1188
1.02
0.03
2.7
2.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
112
1.08
0.03
4.2
3.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
128
0.93
0.02
2.6
4.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
269
0.96
0.02
1.7
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
14
148
0.94
0.02
3.0
5.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
148
0.94
0.02
2.4
2.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
16
168
0.95
0.02
4.0
4.2
%
0.0
0.0
—
5
33
(3015736) pH of Urine
83
839
0.98
0.02
3.0
3.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
17
177
0.96
0.01
4.0
4.2
%
0.0
0.2
—
6
45
(3017181) Myelocytes/100 leukocytes in Blood
18
187
0.96
0.01
3.9
4.1
%
0.7
1.1
—
7
51
(3018677) aPTT in Platelet poor plasma by Coagulation assay
31
303
1.03
0.01
2.5
1.7
s
27.7
29.5
1.92
31
290
(3048689) Calprotectin [Mass/mass] in Stool
27
268
1.01
0.00
1.5
2.0
ug/g
96.3
120.4
0.29
18
212
(3004588) Protein electrophoresis panel - Serum or Plasma
15
151
0.99
0.00
4.7
2.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
17
169
1.01
0.00
4.1
2.5
g/l
67.6
67.3
0.04
17
156
(3014576) Chloride [Moles/volume] in Serum or Plasma
24
239
1.00
0.00
3.8
5.0
mmol/l
104.3
103.8
0.21
24
232
(3001122) Ferritin [Mass/volume] in Serum or Plasma
90
899
1.00
0.00
2.4
2.6
ug/l
137.3
94.7
0.74
81
811
(3037522) Nuclear Ab [Titer] in Serum
31
313
0.99
0.00
1.2
1.3
titre
510.0
699.0
—
8
84
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
113
0.97
0.00
1.5
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
173
0.98
0.00
1.6
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
187
1.02
0.00
1.6
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
12
124
0.97
0.00
4.3
7.3
mmol/l
26.2
25.3
0.39
12
118
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
0.2
—
0
7
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
68
0.88
0.00
1.2
1.2
—
16.2
—
0
5
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
20.7
—
2496.3
—
0
6
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
102.7
—
0
6
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
7
78
0.89
0.00
1.0
1.1
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
18.5
—
1121.3
—
0
6
(40768446) Kidney Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
60
1.00
0.00
1.2
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
108.8
—
0
5
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
58
0.86
0.00
2.0
2.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
89
0.90
0.00
2.6
1.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
8.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
69
1.01
0.00
1.1
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
4.2
2.5
mg/l
1.9
1.5
—
5
43
(4198724)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.7
—
124.1
—
0
9
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST_LOBULAR – Carcinoma in situ of breast, lobular
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).